These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
452 related items for PubMed ID: 6444305
1. Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. Sakata Y, Aoki N. J Clin Invest; 1980 Feb; 65(2):290-7. PubMed ID: 6444305 [Abstract] [Full Text] [Related]
2. Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis. Mimuro J, Kimura S, Aoki N. J Clin Invest; 1986 Mar; 77(3):1006-13. PubMed ID: 2419360 [Abstract] [Full Text] [Related]
3. Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis. Sakata Y, Aoki N. J Clin Invest; 1982 Mar; 69(3):536-42. PubMed ID: 7199538 [Abstract] [Full Text] [Related]
4. Cross-linking of alpha 2-antiplasmin to fibrin is a key factor in regulating blood clot lysis: species differences. van Giezen JJ, Minkema J, Bouma BN, Jansen JW. Blood Coagul Fibrinolysis; 1993 Dec; 4(6):869-75. PubMed ID: 7511944 [Abstract] [Full Text] [Related]
5. Mechanism of ancrod anticoagulation. A direct proteolytic effect on fibrin. Pizzo SV, Schwartz ML, Hill RL, McKee PA. J Clin Invest; 1972 Nov; 51(11):2841-50. PubMed ID: 4263497 [Abstract] [Full Text] [Related]
14. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions. Wu JH, Diamond SL. Thromb Haemost; 1995 Aug 25; 74(2):711-7. PubMed ID: 8585011 [Abstract] [Full Text] [Related]
16. Determinants of substrate specificity for factor XIII. McDonagh J, Fukue H. Semin Thromb Hemost; 1996 Aug 25; 22(5):369-76. PubMed ID: 8989819 [Abstract] [Full Text] [Related]
17. Defective alpha-polymerization in the conversion of fibrinogen Baltimore to fibrin. Brown CH, Crowe MF. J Clin Invest; 1975 Jun 25; 55(6):1190-4. PubMed ID: 1133167 [Abstract] [Full Text] [Related]
18. The effect of fibrin-stabilizing factor on the subunit structure of human fibrin. Schwartz ML, Pizzo SV, Hill RL, McKee PA. J Clin Invest; 1971 Jul 25; 50(7):1506-13. PubMed ID: 5090065 [Abstract] [Full Text] [Related]
19. Acceleration of fibrinolysis by the N-terminal peptide of alpha 2-plasmin inhibitor. Kimura S, Tamaki T, Aoki N. Blood; 1985 Jul 25; 66(1):157-60. PubMed ID: 3159442 [Abstract] [Full Text] [Related]
20. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin. Doolittle RF, Pandi L. Biochemistry; 2006 Feb 28; 45(8):2657-67. PubMed ID: 16489759 [Abstract] [Full Text] [Related] Page: [Next] [New Search]